Entorhinal Cortex Layer II

Entorhinal Cortex Layer II Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Entorhinal Cortex Layer II</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Cortical Layer II Projection Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Layer II of the medial and lateral entorhinal cortex</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Stellate cells, pyramidal cells, fan cells</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitters</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Reelin, Wfs1, Calbindin, Cux1, Cux2</td>
</tr>
<tr>
<td class="label">Vulnerability</td>
<td>Very High in AD</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">Perirhinal Cortex</td>
<td>Lateral perforant path</td>
</tr>
<tr>
<td class="label">Parahippocampal Cortex</td>
<td>Medial perforant path</td>
</tr>
<tr>
<td class="label">Postrhinal Cortex</td>
<td>Medial entorhinal cortex</td>
</tr>
<tr>
<td class="label">Olfactory Bulb</td>
<td>Lateral entorhinal cortex</td>
</tr>
<tr>
<td class="label">Prefrontal Cortex</td>
<td>Indirect via parahippocampus</td>
</tr>
<tr>
<td class="label">Brainstem Nuclei</td>
<td>Noradrenergic, serotonergic</td>
</tr>
<tr>
<td class="label">Factor</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">*Metabolic Demand

Entorhinal Cortex Layer II Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Entorhinal Cortex Layer II</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Cortical Layer II Projection Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Layer II of the medial and lateral entorhinal cortex</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>Stellate cells, pyramidal cells, fan cells</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitters</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>Reelin, Wfs1, Calbindin, Cux1, Cux2</td>
</tr>
<tr>
<td class="label">Vulnerability</td>
<td>Very High in AD</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">Perirhinal Cortex</td>
<td>Lateral perforant path</td>
</tr>
<tr>
<td class="label">Parahippocampal Cortex</td>
<td>Medial perforant path</td>
</tr>
<tr>
<td class="label">Postrhinal Cortex</td>
<td>Medial entorhinal cortex</td>
</tr>
<tr>
<td class="label">Olfactory Bulb</td>
<td>Lateral entorhinal cortex</td>
</tr>
<tr>
<td class="label">Prefrontal Cortex</td>
<td>Indirect via parahippocampus</td>
</tr>
<tr>
<td class="label">Brainstem Nuclei</td>
<td>Noradrenergic, serotonergic</td>
</tr>
<tr>
<td class="label">Factor</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Metabolic Demand</td>
<td>High energy requirements for sustained firing</td>
</tr>
<tr>
<td class="label">Aβ Exposure</td>
<td>Direct toxicity from amyloid deposition</td>
</tr>
<tr>
<td class="label">Tau Propagation</td>
<td>EC-II as staging ground for tau spread</td>
</tr>
<tr>
<td class="label">Vascular Supply</td>
<td>Border zone vulnerability</td>
</tr>
<tr>
<td class="label">Neural Activity</td>
<td>High firing rates increase metabolic stress</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">WFS1</td>
<td>High</td>
</tr>
<tr>
<td class="label">REELIN</td>
<td>High</td>
</tr>
<tr>
<td class="label">CALB1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">CUX1</td>
<td>High</td>
</tr>
<tr>
<td class="label">CUX2</td>
<td>High</td>
</tr>
<tr>
<td class="label">LAMP2</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Technique</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Electrophysiology</td>
<td>In vivo and in vitro recordings</td>
</tr>
<tr>
<td class="label">Calcium Imaging</td>
<td>Network activity monitoring</td>
</tr>
<tr>
<td class="label">Optogenetics</td>
<td>Circuit manipulation</td>
</tr>
<tr>
<td class="label">Tracing Studies</td>
<td>Connectivity mapping</td>
</tr>
<tr>
<td class="label">Single-Cell RNA-seq</td>
<td>Molecular profiling</td>
</tr>
</table>

Introduction

The Entorhinal Cortex Layer II (EC-II) neurons represent a critical gateway between the neocortex and the hippocampus, forming the primary entry point for cortical information into the hippocampal formation. These neurons are among the first and most vulnerable targets in Alzheimer's disease (AD) pathogenesis, making them essential for understanding early AD mechanisms and developing therapeutic interventions. [@witter2006]

Overview

Neuroanatomy

Location and Organization

The entorhinal cortex occupies the medial portion of the parahippocampal gyrus, forming the most lateral region of the parahippocampal cortex. Layer II is characterized by a dense band of large, densely packed neurons that form the primary projection neurons of the entorhinal-hippocampal circuit. [@moehlmann2002]

The medial entorhinal cortex (MEC) and lateral entorhinal cortex (LEC) show distinct organizational patterns: [@canto2018]

• MEC Layer II: Dominated by stellate cells organized in a grid-like manner, projecting primarily to the dentate gyrus
• LEC Layer II: Contains both stellate and pyramidal neurons, projecting to CA3 and subiculum

Cellular Morphology

Stellate Cells: [@squire1996]

• Large cell bodies (20-30 μm diameter)
• Dendritic trees extending in all directions
• Spiny dendrites receiving excitatory inputs
• Regular spiking phenotype

• Pyramidal-shaped soma
• Dendritic arborization in layer I
• Found primarily in the ventral MEC

Connectivity

Afferent Inputs (Inputs to EC-II)

EC-II neurons receive diverse cortical and subcortical inputs:

Efferent Outputs (Outputs from EC-II)

EC-II neurons project to the hippocampal formation via two major pathways:

This positions EC-II as the primary gateway for cortical information entering the hippocampus.

Normal Function

Memory Encoding

EC-II neurons play essential roles in:

• Pattern Separation: Transforming similar cortical inputs into distinct hippocampal representations
• Spatial Navigation: Grid cells in MEC layer II provide metric for spatial representation
• Memory Initialization: Setting the initial hippocampal encoding state
• Contextual Processing: Integrating multisensory contextual information

Neural Coding

• Grid Cell Properties: MEC layer II stellate cells exhibit grid-like firing patterns in spatial environments
• Object-Space Coupling: LEC layer II neurons encode object information in spatial contexts
• Theta Rhythm Coupling: Firing synchronized to theta oscillations (6-10 Hz)

Role in Alzheimer's Disease

Early Vulnerability

EC-II neurons are among the first to exhibit pathological changes in AD:

Mechanisms of Vulnerability

Several factors contribute to EC-II vulnerability in AD:

Therapeutic Implications

Understanding EC-II vulnerability has led to therapeutic strategies:

• Early Detection: EC-II dysfunction serves as an early biomarker
• Neuroprotection: Targeting EC-II-specific vulnerabilities
• Circuit Restoration: Repairing perforant path connectivity
• Tau-Targeting: Preventing EC-II tau pathology progression

Molecular Characteristics

Gene Expression Markers

Receptor Expression

• NMDA Receptors: GluN2A/B subunits
• AMPA Receptors: GluA1-4 subunits
• mGluR5: Metabotropic glutamate signaling
• GABA-A Receptors: Inhibitory modulation

Experimental Models

Animal Models

• Mice: Wild-type and transgenic AD models (APP/PS1, 3xTg-AD)
• Rats: Non-human primate studies for translational relevance
• In Vitro: Primary neuronal cultures, organotypic slices

Research Techniques

See Also

• [Entorhinal Cortex Layer II Neurons in Alzheimer's Disease
• Entorhinal Cortex Layer III](/cell-types/entorhinal-cortex-layer-ii-neurons-in-alzheimer's-disease

• [Entorhinal Cortex](/brain-regions/entorhinal-cortex)
• Perforant Path
• Hippocampal Formation
• [Grid Cells](/cell-types/grid-cells)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Alzheimer's Disease](/diseases/alzheimers-disease)

External Links

• [Allen Brain Atlas: Entorhinal Cortex](https://human.brain-map.org/)
• [BrainSpan Atlas: Developmental Gene Expression](https://www.brainspan.org/)
• [UniProt: Human Entorhinal Cortex](https://www.uniprot.org/)
• [PubMed: Entorhinal Cortex Alzheimer's](https://pubmed.ncbi.nlm.nih.gov/)

Background

The study of Entorhinal Cortex Layer Ii has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Perforant Path Presynaptic Terminal Protection Strategy](/hypothesis/h-76888762) — <span style="color:#81c784;font-weight:600">0.69</span> · Target: PPARGC1A
• [Tau-Independent Microtubule Stabilization via MAP6 Enhancement](/hypothesis/h-e12109e3) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: MAP6
• [Reelin-Mediated Cytoskeletal Stabilization Protocol](/hypothesis/h-d2df6eaf) — <span style="color:#81c784;font-weight:600">0.62</span> · Target: RELN
• [HCN1-Mediated Resonance Frequency Stabilization Therapy](/hypothesis/h-d40d2659) — <span style="color:#81c784;font-weight:600">0.62</span> · Target: HCN1
• [Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioenergetics](/hypothesis/h-5ff6c5ca) — <span style="color:#ffd54f;font-weight:600">0.55</span> · Target: SLC16A2
• [Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancement](/hypothesis/h-57862f8a) — <span style="color:#ffd54f;font-weight:600">0.51</span> · Target: IDH2
• [Mitochondrial Calcium Buffering Enhancement via MCU Modulation](/hypothesis/h-aa8b4952) — <span style="color:#ffd54f;font-weight:600">0.49</span> · Target: MCU

• [Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) &#x1f504;